Clinical Trials Browser

Sarcoma, Synovial, Liposarcoma, Myxoid

NCT06843967 2026-03-13

A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma

Phase 1/2 Recruiting

54 enrolled

Sarcoma

Liposarcoma, Liposarcoma, Myxoid

NCT04794127 2026-02-18

TRABEPIO

Phase 2 Completed

10 enrolled

Sarcoma

Liposarcoma, Liposarcoma, Myxoid

NCT06239272 2026-01-26

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Phase 1/2 Recruiting

139 enrolled

Plasma cellSarcoma

Histiocytoma, Angiomatoid Fibrous, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Glomus Tumor, Granuloma, Plasma Cell, Hemangiosarcoma, Liposarcoma, Myoepithelioma, Sarcoma, Osteosarcoma, Disorders of Sex Development, Granular Cell Tumor, Neoplasms, Adipose Tissue, Liposarcoma, Myxoid, Dermatofibrosarcoma, Sarcoma, Clear Cell, Smooth Muscle Tumor, Nerve Sheath Neoplasms, Neurofibrosarcoma, Hemangioendothelioma, Epithelioid, Vascular Neoplasms, Solitary Fibrous Tumors

NCT07261657 2025-12-03

N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy

Phase EARLY_PHASE1 Not yet recruiting

8 enrolled

Sarcoma

Sarcoma, Synovial, Liposarcoma, Myxoid

NCT06414434 2025-10-31

BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma

Phase 1 Recruiting

24 enrolled

Sarcoma

Liposarcoma, Liposarcoma, Myxoid

NCT03670069 2024-05-08

Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas

Phase 1 Terminated

27 enrolled

Sarcoma

Chondrosarcoma, Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Liposarcoma, Myxoid, Histiocytoma, Malignant Fibrous

NCT03450122 2023-10-16

Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma

Phase 1 Completed

15 enrolled

Sarcoma

Sarcoma, Synovial, Liposarcoma, Myxoid

NCT03399448 2023-06-22

NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells)

Phase 1 Terminated

3 enrolled

DermatologicPlasma cellSarcoma

Melanoma, Multiple Myeloma, Sarcoma, Synovial, Liposarcoma, Myxoid

NCT02275286 2023-05-31

TRASTS

Phase 1/2 Recruiting

199 enrolled

Sarcoma

Leiomyosarcoma, Liposarcoma, Sarcoma, Liposarcoma, Myxoid

NCT04699292 2022-08-30

International Prospective Registry on Local Treatment Approaches in MLS

Recruiting

300 enrolled

Sarcoma

Liposarcoma, Myxoid

NCT02821507 2022-04-20

Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma

Phase 2 Completed

70 enrolled

Sarcoma

Liposarcoma, Myxoid, Chondrosarcoma, Mesenchymal

NCT04512495 2021-12-10

SAMHY SARCOME

Phase NA Completed

60 enrolled

Sarcoma

Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial, Liposarcoma, Myxoid

NCT02106312 2021-08-04

DOREMY

Phase 2 Unknown

80 enrolled

Sarcoma

Sarcoma, Liposarcoma, Myxoid

NCT03989596 2021-02-01

SINDIR

Phase 2 Unknown

30 enrolled

Sarcoma

Hyperthermia, Fibrosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Liposarcoma, Myxoid, Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT03651375 2021-01-22

UN-RESARC

Phase 2 Unknown

46 enrolled

Sarcoma

Fibrosarcoma, Leiomyosarcoma, Liposarcoma, Lymphangiosarcoma, Myosarcoma, Sarcoma, Sarcoma, Synovial, Liposarcoma, Myxoid, Dermatofibrosarcoma, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous, Histiocytic Sarcoma

NCT03397186 2019-09-10

Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma

Phase 2 Withdrawn

Sarcoma

Sarcoma, Liposarcoma, Myxoid

NCT01957709 2019-07-10

Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma

Phase EARLY_PHASE1 Terminated

8 enrolled 9 charts

Sarcoma

Sarcoma, Synovial, Liposarcoma, Myxoid

NCT03816475 2019-06-17

LIPOMYX

Phase 2 Unknown

35 enrolled

Sarcoma

Sarcoma, Liposarcoma, Myxoid

NCT02059850 2016-02-03

NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

Phase 1 Withdrawn

Sarcoma

Sarcoma, Sarcoma, Synovial, Liposarcoma, Myxoid

Clinical Trials

Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1

A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma

TRABEPIO

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy

BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma

Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas

Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma

NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells)

TRASTS

International Prospective Registry on Local Treatment Approaches in MLS

Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma

SAMHY SARCOME

DOREMY

SINDIR

UN-RESARC

Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma

Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma

LIPOMYX

NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma